Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | PGR | P06401 | 1/20 | 0.47 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.47 |
| ▸ | ERN1 | O75460 | 1/20 | 0.46 |
| ▸ | CHEK1 | O14757 | 3/20 | 0.44 |
| ▸ | PRKDC | P78527 | 2/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | HTR1D | P28221 | 1/20 | 0.42 |
| ▸ | HTR1B | P28222 | 1/20 | 0.42 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.41 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.40 |
| ▸ | GPR17 | Q13304 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14302816 | 0.89 | DPP4 (0.45) | KCNH2PGRSLC6A11ERN1CHEK1 | |
| SCHEMBL12319844 | 0.81 | KCNH2 (0.44) | KCNH2PGRSLC6A11ERN1PRKDC | |
| SCHEMBL12402896 | 0.80 | KCNH2 (0.57) | KCNH2PGRSLC6A11ERN1CHEK1 | |
| SCHEMBL23954203 | 0.79 | KCNH2 (0.47) | KCNH2PGRSLC6A11ERN1CHEK1 | |
| SCHEMBL13615853 | 0.79 | KCNH2 (0.55) | KCNH2PGRSLC6A11ERN1CHEK1 | |
| SCHEMBL12405261 | 0.77 | KCNH2 (0.53) | KCNH2PGRSLC6A11ERN1CHEK1 | |
| SCHEMBL14579976 | 0.76 | SNCA (0.43) | PGR | |
| SCHEMBL13009526 | 0.75 | MAOB (0.37) | — | |
| SCHEMBL13615737 | 0.74 | KCNH2 (0.50) | KCNH2PGRSLC6A11ERN1LTA4H | |
| SCHEMBL13615898 | 0.74 | KCNH2 (0.50) | KCNH2PGRSLC6A11ERN1LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080248583-A1 | Quantitative and Qualitative Chelation Measuring Methods and Materials | ALBION LABORATORIES, INC. (US) | 2008-10-09 | — | — | US | claimed |
| WO-2006034195-A2 | QUANTITATIVE AND QUALITATIVE CHELATION MEASURING METHODS AND MATERIALS | ALBION LABORATORIES, INC. (US) | 2006-03-30 | — | — | WO | claimed |
| US-20080248583-A1 | Quantitative and Qualitative Chelation Measuring Methods and Materials | ALBION LABORATORIES, INC. (US) | 2008-10-09 | — | — | US | disclosed |
| US-7179306-B2 | Process for dying keratin fibers comprising at least one aryl or aryloxy substitutent-based ninhydrin derivative | L'OREAL S.A. (FR) | 2007-02-20 | — | — | US | disclosed |
| US-7179306-B2 | Process for dying keratin fibers comprising at least one aryl or aryloxy substitutent-based ninhydrin derivative | L'OREAL S.A. (FR) | 2007-02-20 | — | — | US | disclosed |
| WO-2006034195-A2 | QUANTITATIVE AND QUALITATIVE CHELATION MEASURING METHODS AND MATERIALS | ALBION LABORATORIES, INC. (US) | 2006-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080248583-A1 | Quantitative and Qualitative Chelation Measuring Methods and Materials | AAAS, LIG4, HAMP | KCNH2 2756/4885PGR 2369/4885SLC6A11 3433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.